
CRL
Charles River Laboratories
$219.62
$3.94 (-1.76%)
Sabtu, 17 Januari 2026 03:59 WIB
$219.62
$3.94 (-1.76%)
Sabtu, 17 Januari 2026 03:59 WIB
10.99 B
Market Cap
Harga kembali 1 minggu-0.51%
Harga kembali 1 Bulan12.62%
Harga kembali 3 Bulan25.82%
Harga kembali 6 Bulan41.91%
Harga Tertinggi (52 Minggu)228.24
Harga Terendah (52 Minggu)92
Latar Belakang Perusahaan
Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the Pharmaceutical, Medical device and Biotechnology industries. It also supplies assorted biomedical products and outsourcing services for research and development in the pharmaceutical industry and offer support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.
Summary
Valuation Information
Current PE Ratio (TTM)-144.48
Forward PE Ratio20.79
Current Price to Book Value3.17
Current Price to Sales2.73
EV to Revenue3.33
EV to EBITDA25.99
PEG Ratio8.35
Per Share
Current EPS (Annualized)-1.52
Diluted EPS (TTM)-1.52
Revenue Per Share80.4
Current Book Value Per Share69.19
Dividend
Dividend Per Share-
Dividend Yield-
Ex Dividend Date-
Dividend Payment Date-
Income Statement
EBITDA884891000
Profit Margin-0.0205
Operating Margin0.15
Feed
Berita
Broker Summary
Technical
Finansial
Laporan
Profil

23 Juli 2025, 09:47 WIB